CCL13, also known as MCP-4 (monocyte chemoattractant protein 4), is a ligand for several receptors (CCR1, CCR2, CCR3, CCR5, and CCR11), and it has a significant impact on the immune response and HL microenvironment. Here, CCR5 is linked to Hodgkins lymphoma.